Antidepressant Tablet Franchise in Ahmedabad

Psychiatry Medicine Supplier in Mumbai

Anxiety Medicine Distributor in Delhi

Paroxetine Tablet Manufacturer in Bangalore

Neuro Tablet Stockist in Hyderabad
Psychiatry Tablet Exporter in Chandigarh

Home/Products /paroxetine-37-5mg-tablet

Paroxyle 37.5mg CR Tablet

Composition : Paroxetine (37.5mg) Tablet

Dosage Form : Tablet

Packaging Type : Strip

Packaging : 10*10

Price : ₹1/-

Paroxyle 37.5 mg CR Tablet contains Paroxetine, a widely prescribed antidepressant used for the treatment of depression, anxiety disorders, panic attacks, and mood-related conditions. It helps improve emotional stability and enhances overall mental well-being.

Paroxetine works by selectively inhibiting the reuptake of serotonin in the brain, which plays a key role in regulating mood and behavior. The controlled release formulation ensures gradual drug delivery, providing sustained therapeutic action and improved patient compliance.

This medicine is commonly used in psychiatric treatment plans for long-term management of mental health conditions. Its effectiveness in reducing symptoms such as stress, anxiety, and depressive episodes makes it a preferred choice among healthcare professionals.

With rising awareness about mental health and increasing demand for psychiatric medicines, this product offers strong market potential. Its consistent prescription demand, long-term usage, and growing acceptance make it a reliable option for expanding business in the neuro and psychiatry segment.

Read More

About the Product

Paroxyle 37.5 mg CR Tablet contains Paroxetine, a widely prescribed antidepressant used for the treatment of depression, anxiety disorders, panic attacks, and mood-related conditions. It helps improve emotional stability and enhances overall mental well-being.

Paroxetine works by selectively inhibiting the reuptake of serotonin in the brain, which plays a key role in regulating mood and behavior. The controlled release formulation ensures gradual drug delivery, providing sustained therapeutic action and improved patient compliance.

This medicine is commonly used in psychiatric treatment plans for long-term management of mental health conditions. Its effectiveness in reducing symptoms such as stress, anxiety, and depressive episodes makes it a preferred choice among healthcare professionals.

With rising awareness about mental health and increasing demand for psychiatric medicines, this product offers strong market potential. Its consistent prescription demand, long-term usage, and growing acceptance make it a reliable option for expanding business in the neuro and psychiatry segment.

Some patients may experience nausea, dizziness, dry mouth, insomnia or drowsiness, and sexual dysfunction. Other possible effects include sweating, weakness, or changes in appetite and weight. In rare cases, mood changes or suicidal thoughts may occur, particularly during the early stages of therapy.

Paroxyle 37.5 mg CR Tablet (Paroxetine 37.5 mg) is indicated for the treatment of depression, generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, and obsessive-compulsive disorder (OCD). It helps stabilize mood, reduce anxiety, control panic episodes, and improve overall mental well-being.

This medication should be taken strictly under medical supervision. Do not discontinue abruptly, as it may lead to withdrawal symptoms. Dose adjustments should be made only by a healthcare professional. Avoid alcohol and inform your doctor about any ongoing medications or medical conditions.

Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep in the original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation